From the Journals
Conference News
Universal Aspirin in High-Risk Pregnancies?
-
By
February 11, 2026
-
3 min
-
1
Aspirin reduces preeclampsia rates by 29%.
-
2
Daily intake is 162 mg for high-risk pregnancies.
-
3
Implementation began August 3,
-
4
Postpartum hemorrhage rates decreased from 9.5% to 8.9%.
-
5
The study focused on a predominantly Hispanic population.
-
6
No significant harm from aspirin was reported.
-
7
Findings are observational and may not generalize to all populations.
-
A recent cohort study presented at the Society for Maternal-Fetal Medicine 2026 Pregnancy Meeting suggests that universal aspirin dispensation at the first prenatal visit can reduce the rate of preeclampsia with severe features by 29% in high-risk populations. Following the implementation of daily 162 mg aspirin for patients under 16 weeks' gestation at a Dallas public hospital in August 2022, rates of severe preeclampsia and gestational hypertension decreased. The study noted a decline in postpartum hemorrhage and stable rates for placental abruption. Despite limitations in generalizing findings, researchers noted no harm from aspirin use, indicating a potential for improved prenatal care strategies.
-
1
Aspirin reduces preeclampsia rates by 29%.
-
2
Daily intake is 162 mg for high-risk pregnancies.
-
3
Implementation began August 3,
-
4
Postpartum hemorrhage rates decreased from 9.5% to 8.9%.
-
5
The study focused on a predominantly Hispanic population.
-
6
No significant harm from aspirin was reported.
-
7
Findings are observational and may not generalize to all populations.
Listen Tab content
